ABOUT HALLORAN CONSULTING GROUP
Halloran Consulting Group, a ProductLifeGroup company, is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support in the pharmaceutical, biotechnology, and medical device sectors in the United States. Founded in 1998 by Laurie Halloran, the company is known for offering comprehensive solutions to help clients navigate complex regulatory environments, optimize operations, and accelerate product development. The Halloran team empowers clients to achieve critical business milestones, ensure product quality and safety, and maintain competitive advantage in highly regulated environments. The company has a bi-coastal presence with offices located in Boston, MA and San Diego, CA. Their team of subject matter experts takes a customized approach to each engagement, effectively guiding their clients toward their next pivotal moment. They are trusted industry partners whose expertise offers operational excellence and fosters innovation across the life sciences ecosystem. Their goal is to support clients and the patients they serve.
FEATURED ARTICLE
Risk Mitigation Planning For Pharmaceutical Tariffs
Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.
THOUGHT LEADERSHIP
-
![GettyImages-1464673521-tablet-scientist-paper-checking-pen-hand-writing]( "ICH E6(R3) And A Risk-Based Approach As A Competitive Advantage")
ICH E6 (R3) advocates for a streamlined, risk-informed trial design that enhances quality and participant experience, paving the way for more efficient and successful clinical research outcomes.
-
![GettyImages-2174048702-2025-lightbulb-insights]( "Halloran's Regulatory Lens – What We're Watching In 2025")
As the regulatory environment evolves in 2025, product developers face increasing complexity driven by external pressures such as tariffs and internal shifts like FDA personnel changes.
-
![GettyImages-1572384472 recall, packaging, shipping]( "Risk Mitigation Planning For Pharmaceutical Tariffs")
Examine the potential ramifications of proposed tariffs on the pharmaceutical and biotechnology sectors, highlighting critical concerns regarding national security and supply chain stability.
-
![deadlines time management-GettyImages-1350531674]( "Ticking Timeline: Tips For Effective Product Development Timelines")
Biotech and pharmaceutical companies must establish clear product development objectives and well-designed timeline to navigate the drug development lifecycle effectively.
-
![GettyImages-1221852665-not tested on animals]( "How The FDA Is Phasing Out Animal Testing Requirement")
The FDA is embarking on a transformative initiative to phase out animal testing requirements.
-
![Digital Globe]( "Key Update On Guideline For Good Clinical Practice E6(R3)")
Review details of the adoption of ICH GCP E6 R3 Principles and Annex 1, as well as what preparations and next steps your organization will need to undertake.
-
![Risk Management-GettyImages-665231256]( "Pathway To Success: How De-Risking Life Sciences Companies Leads To Investment Growth")
De-risking in clinical development is essential to optimizing trial success and ensuring regulatory approval and strategic decision-making at critical points in a study’s lifecycle can minimize uncertainties.
CONTACT INFORMATION
Halloran Consulting
22 Thompson Place
Boston, MA 02210
UNITED STATES
Phone: 978.482.6237
Contact: Gail Winslow, Head of Marketing
CALIFORNIA ADDRESS
3040 Science Park Road, Suite 1300
San Diego, CA 92121
PRESS RELEASES
- ProductLife Group (PLG) Acquires Halloran To Further Expand Its Global Reach And Capabilities To Support The Development Of New Therapies
- Halloran Wins The Life Science Cares Transformative Partnership Award
- Halloran Celebrates 25th Anniversary Milestone
EXPERT RESOURCES
-
![Business Meeting-GettyImages-1831418247]( "Organizational Assessment For A Large MedTech Company")
Explore an organizational assessment run for a medical technology company specializing in tissue repair and regeneration, and the actionable recommendations provided to facilitate future growth.
-
![GettyImages-466728721 quality]( "GxP Quality Assessment And Remediation")
Ensure regulatory compliance and foster continuous improvement through the use of comprehensive GxP quality assessment and remediation services.
-
![GettyImages-1002000796-lab-research-scientist-development]( "Regulatory Special Designations")
Discover how securing an FDA special designation can accelerate your drug development process and bring life-saving therapies to market faster.
-
![Documentation Traps]( "Investigational New Drug Application Support")
When faced with industry pressures, companies seek out essential support to ensure their product's market plan is grounded in expert guidance.
-
![Personal data security-GettyImages-1172943967]( "GxP Data Integrity: Assessment, Readiness, And Compliance")
Our team comprises seasoned professionals in life sciences and regulatory compliance, offering tailored solutions for your unique data integrity challenges.
-
![GettyImages-1296272795-plan-planning-strategy]( "Why Regulatory CMC Strategy Is Crucial To Drug Development Projects")
Our goal is to provide comprehensive Reg CMC strategic advising that not only aligns with regulatory expectations but also enhances the efficiency and success of your drug development efforts.
-
![iStock-1275682432-inspection-regulatory]( "Inspection Readiness")
Learn how your company can enable productive interactions with inspectors through Inspection Readiness (IR) gap assessments, and propel to the next phase of development.
-
![Field Technologies Trusted Advisor]( "Strategic Advising For Lifecycle Development: Navigating Complexity With Precision")
Discover tailored strategies crafted to align with your company's goals and objectives that draw upon extensive past, present, and ongoing experiences to drive success at each pivotal stage of your journey.
